Chembio diagnostics, Inc.
CEMI
CEMI was delisted on the 27th of April, 2023.
72 hedge funds and large institutions have $24.5M invested in Chembio diagnostics, Inc. in 2021 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 18 increasing their positions, 30 reducing their positions, and 12 closing their positions.
2% less call options, than puts
Call options by funds: $634K | Put options by funds: $646K
6% less funds holding
Funds holding: 77 → 72 (-5)
39% less capital invested
Capital invested by funds: $39.8M → $24.5M (-$15.4M)
40% less repeat investments, than reductions
Existing positions increased: 18 | Existing positions reduced: 30
42% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 12
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PCM
Perkins Capital Management
Wayzata,
Minnesota
|
+$1.61M |
| 2 |
Renaissance Technologies
New York
|
+$861K |
| 3 |
JP Morgan Chase
New York
|
+$480K |
| 4 |
BlackRock
New York
|
+$358K |
| 5 |
EGM
Engineers Gate Manager
New York
|
+$199K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FA
Friess Associates
Greenville,
Delaware
|
-$2.29M |
| 2 |
USPCM
Union Square Park Capital Management
New York
|
-$1.81M |
| 3 |
Goldman Sachs
New York
|
-$1.05M |
| 4 |
SMH
Sanders Morris Harris
Houston,
Texas
|
-$990K |
| 5 |
Marshall Wace
London,
United Kingdom
|
-$841K |
CEMI Hedge Fund Activity: Q1 2021 in Review
72 of the 5,696 institutional investors tracked by Wall St. Rank reported a position in Chembio diagnostics, Inc. (CEMI) for Q1 2021, worth a combined $24.5M — down 39% from $39.8M a quarter earlier.
Sellers outnumbered buyers: 12 funds closed out of CEMI and 7 opened new positions — a net loss of 5 holders — while 30 trimmed existing stakes and 18 added.
The largest buyer was Perkins Capital Management, opening a new position worth an estimated $1.61M. The largest seller was Friess Associates, cutting an estimated $2.29M.
- 72 institutional investors held Chembio diagnostics, Inc. (CEMI) as of Q1 2021, down from 77 in Q4 2020.
- Funds reported $24.5M of Chembio diagnostics, Inc. stock for Q1 2021, down 39% quarter-over-quarter.
- 7 funds opened new Chembio diagnostics, Inc. positions in Q1 2021 and 12 closed out, a net change of -5 holders.
- The largest Chembio diagnostics, Inc. buyer in Q1 2021 was Perkins Capital Management, an estimated $1.61M added.
- The largest Chembio diagnostics, Inc. seller in Q1 2021 was Friess Associates, an estimated $2.29M sold.
Based on aggregated 13F filings for Q1 2021.